Is a complete THC research report available?

No complete published report is available for Tenet Healthcare Corporation (THC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

THC Stock Analysis, Forecast & Valuation

Market cap	22.6B
Revenue (ttm)	21.8B
Net income (ttm)	2.2B
EPS (ttm)	$25.7
Shares out	86.1M
P/E (trailing)	10.2x
P/E (forward)	12.9x
Volume	1,830,763
Beta	1.27

Price target	$277	+5.7%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All THC indicators

Market & fundamental data

Available fields

283

Groups with data

Currency

USD

Showing 283 of 283 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000070318
Company name	Tenet Healthcare Corporation
Country	United States
Country code	US
Cusip	88033G407
Employees	99,000
Employees Change	1,000%
Employees Change Percent	1.02
Enterprise value	$33.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Industry PE	16.17
Industry PE Fwd	15.24
Isin	US88033G4073
Last refreshed	2026-07-29
Market cap	$22.6B
Market cap category	Large-Cap
Price	$263
Price currency	USD
Rev Per Employee	220,323.23x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	8062
Symbol	THC
Website	https://www.tenethealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.12%
EV Earnings	14.83x
EV Sales Forward	1.5x
EV/EBIT	7.77x
EV/EBITDA	6.43x
EV/FCF	10.99x
EV/Sales	1.52x
FCF yield	13.65%
Forward P/E	12.92x
P/B ratio	4.36x
P/E ratio	10.2x
P/S ratio	1.02x
PE Ratio3 Y	8.89x
PE Ratio5 Y	9.66x
PEG ratio	0.96x
PS Forward	1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.89%
EBITDA Margin	22.83%
FCF margin	13.86%
Gross margin	41.66%
Gross Profit	$9.1B
Gross Profit Growth	7.74%
Gross Profit Growth Q	10.84%
Gross Profit Growth3 Y	7.34%
Gross Profit Growth5 Y	5.13%
Net Income	$2.2B
Net Income Growth	51.01%
Net Income Growth Q	186.81%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	64.99%
Net Income Growth5 Y	38.86%
Pretax Margin	17.72%
Profit Margin	10.27%
Profit Per Employee	$22,636
Profitable Quarters	$22
Profitable Years	6
ROA	8.26
Roa5y	6.58
ROCE	17.03
ROE	37.34
Roe5y	34.94
ROIC	16.59
Roic5y	12.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	23.94%
Cagr15y	17.71%
Cagr1y	71.7%
Cagr20y	12.75%
Cagr3y	53.02%
Cagr5y	29.65%
Div CAGR10	-30.02%
Div CAGR3	-72.48%
Div CAGR5	-53.89%
EPS Growth	64.5
EPS Growth Q	213.4
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	77.12
EPS Growth5 Y	44.92
FCF Growth	94.66%
FCF Growth Q	-43.88%
FCF Growth3 Y	46.52%
FCF Growth5 Y	17.97%
OCF Growth	62.88%
OCF Growth Q	-37.5%
OCF Growth10 Y	12.33%
OCF Growth3 Y	31.07%
OCF Growth5 Y	17.17%
Revenue Growth	5.46x
Revenue Growth Q	6.77x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	3.12x
Revenue Growth5 Y	2.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.73
Assets	$30.7B
Cash	$2.2B
Current Assets	$7.8B
Current Liabilities	$5.6B
Debt	$13.2B
Debt EBITDA	$2.56
Debt Equity	$1.52
Debt FCF	$4.38
Equity	$8.7B
Interest Coverage	5.21
Liabilities	$22B
Long Term Assets	$22.8B
Long Term Liabilities	$16.4B
Net Cash	$-11.1B
Net Cash By Market Cap	$-50.01
Net Debt EBITDA	$2.14
Net Debt Equity	$1.27
Net Debt FCF	$3.66
Tangible Book Value	$-8.1B
Tangible Book Value Per Share	$-96.5
WACC	8.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.41
Inventory Turnover	37.65
Net Working Capital	$250M
Quick ratio	0.86
Working Capital	$2.3B
Working Capital Turnover	$8.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	8.21%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$0.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	754.92%
1Y total return	71.63%
200-day SMA	199.4
3Y total return	258.39%
50-day SMA	188.2
50-day SMA vs 200-day SMA	50under200
5Y total return	266.24%
All Time High	262.7
All Time High Change	-0.02%
All Time High Date	2026-07-28
All Time Low	0.42
All Time Low Change	62,297.24%
All Time Low Date	1974-09-16
ATR	11.4
Beta	1.27
Beta1y	0.84
Beta2y	0.99
Ch YTD	32.16
High	262.7
High52	262.7
High52 Date	2026-07-28
High52ch	-0.02%
Low	246.1
Low52	151
Low52 Date	2025-07-28
Low52ch	73.93%
Ma50ch	39.55%
Premarket Change Percent	1.57
Premarket Price	$247
Premarket Volume	3,406
Price vs 200-day SMA	31.68%
RSI	80.8
RSI Monthly	67.76
RSI Weekly	68.27
Sharpe ratio	1.37x
Sortino ratio	2.68
Total Return	8.21%
Tr YTD	32.16
Tr15y	1,053.91%
Tr1m	38.96%
Tr1w	33.66%
Tr3m	41.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	22
Analyst Count Top	8
Analyst Price Target Top	$273
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$4.2
Earnings EPS Estimate Growth	4.48
Earnings Revenue Estimate	5,420,868,344x
Earnings Revenue Estimate Growth	2.84x
Operating Income	$3.9B
Operating Income Growth	11.6
Operating Income Growth Q	20.47
Operating Income Growth3 Y	14.35
Operating Income Growth5 Y	11.44
Operating margin	17.99
Price target	$277
Price Target Change	$5.65
Price Target Change Top	$4.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	85,122,158%
Float Percent	98.82%
Net Borrowing	-80,000,000
Shares Insiders	1.05%
Shares Institutions	96.68%
Shares Out	86,137,000
Shares Qo Q	-4.15%
Shares Yo Y	-8.21%
Short Float	3.5%
Short Ratio	2.24
Short Shares	3.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.9B
Adjusted OCF	3,883,000,000
Average Volume	1,491,937.15x
Bv Per Share	55.77
CAPEX	$-992M
Ch10y	754.9
Ch15y	1,053.9
Ch1m	38.96
Ch1w	33.66
Ch1y	71.63
Ch20y	1,001.6
Ch3m	41.56
Ch3y	258.4
Ch5y	266.2
Ch6m	38.85
Change	7.92%
Change From Open	6.53
Close	243.4
Days Gap	1.31
Depreciation Amortization	893,000,000
Dollar Volume	480,813,286.7
Earnings Date	2026-07-23
Earnings Time	amc
EBIT	$4.3B
EBITDA	$5.2B
EPS	$25.75
F Score	6
FCF	$3B
FCF EV Yield	9.1x
FCF Per Share	$35.1
Financing CF	-3,176,000,000
Fiscal Year End	December
Founded	1,967
Goodwill	11,437,000,000
Graham Number	179.75147
Graham Upside	-30.1
Income Tax	$691M
Investing CF	-1,294,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-23
Last Report Date	2026-06-30
Last Split Date	2012-10-11
Last Split Type	Reverse
Last10k Filing Date	2026-02-17
Lynch Fair Value	$644
Lynch Upside	150.3
Ma150	198.4
Ma150ch	32.37%
Ma20	205.2
Ma20ch	28%
Net CF	-455,000,000
Next Earnings Date	2026-10-27
Open	246.5
Optionable	Yes
P FCF Ratio	7.33
P FCF Ratio SBC	7.66
P OCF Ratio	5.52
P OCF Ratio SBC	5.7
Position In Range	99.7
Post Close	262.6
Postmarket Change Percent	0.14
Postmarket Price	$263
Ppne	6,258,000,000
Pre Close	243.4
Price Date	2026-07-28
Price EBITDA	$4.29
Relative Volume	1.23x
Revenue	21,812,000,000x
SBC By Revenue	0.61x
Share Based Comp	132,000,000
Tax By Revenue	3.17x
Tax Rate	17.88%
Tr20y	1,001.64%
Tr6m	38.85%
Us State	Texas
Volume	1,830,763
Z Score	1.96

Tenet Healthcare Corporation (THC)

Coverage state: Market snapshot only — no published research

Generate the first THC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · THC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All THC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on THC

Frequently asked questions